MHRA Class 4 Medicines Defect Information: Lemsip Max Cold and Flu Capsules (Reckitt Benckiser Healthcare (UK) Limited)
Class 4 Medicines Defect Information: Lemsip Max Cold and Flu Capsules (Reckitt Benckiser Healthcare (UK) Limited) Drug alert number: EL (23)A/04 Date issued: 22 February 2023 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Lemsip Max Cold and Flu Capsules, PL 00063/0104 Batch number Expiry [...]
The post MHRA Class 4 Medicines Defect Information: Lemsip Max Cold and Flu Capsules (Reckitt Benckiser Healthcare (UK) Limited) appeared first on PSNC Website.
Recent Comments